Bank of New York Mellon’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $612K | Buy |
184,916
+16,028
| +9% | +$53.1K | ﹤0.01% | 3382 |
|
|
2025
Q1 | $490K | Sell |
168,888
-2,793
| -2% | -$8.1K | ﹤0.01% | 3435 |
|
|
2024
Q4 | $611K | Sell |
171,681
-6,014
| -3% | -$21.4K | ﹤0.01% | 3397 |
|
|
2024
Q3 | $885K | Sell |
177,695
-50,656
| -22% | -$252K | ﹤0.01% | 3201 |
|
|
2024
Q2 | $594K | Buy |
+228,351
| New | +$594K | ﹤0.01% | 3478 |
|
|
2024
Q1 | – | Sell |
-14,853
| Closed | -$30K | – | 4153 |
|
|
2023
Q4 | $30K | Hold |
14,853
| – | – | ﹤0.01% | 4192 |
|
|
2023
Q3 | $22.7K | Hold |
14,853
| – | – | ﹤0.01% | 4237 |
|
|
2023
Q2 | $24.5K | Hold |
14,853
| – | – | ﹤0.01% | 4259 |
|
|
2023
Q1 | $16.9K | Hold |
14,853
| – | – | ﹤0.01% | 4321 |
|
|
2022
Q4 | $13.4K | Hold |
14,853
| – | – | ﹤0.01% | 4392 |
|
|
2022
Q3 | $17K | Hold |
14,853
| – | – | ﹤0.01% | 4463 |
|
|
2022
Q2 | $10K | Sell |
14,853
-99,770
| -87% | -$67.2K | ﹤0.01% | 4544 |
|
|
2022
Q1 | $299K | Hold |
114,623
| – | – | ﹤0.01% | 4022 |
|
|
2021
Q4 | $446K | Sell |
114,623
-420
| -0.4% | -$1.63K | ﹤0.01% | 3875 |
|
|
2021
Q3 | $502K | Sell |
115,043
-680
| -0.6% | -$2.97K | ﹤0.01% | 3801 |
|
|
2021
Q2 | $459K | Sell |
115,723
-48,536
| -30% | -$193K | ﹤0.01% | 3802 |
|
|
2021
Q1 | $854K | Buy |
164,259
+74,240
| +82% | +$386K | ﹤0.01% | 3418 |
|
|
2020
Q4 | $482K | Buy |
90,019
+39,093
| +77% | +$209K | ﹤0.01% | 3630 |
|
|
2020
Q3 | $247K | Sell |
50,926
-8,342
| -14% | -$40.5K | ﹤0.01% | 3776 |
|
|
2020
Q2 | $288K | Buy |
+59,268
| New | +$288K | ﹤0.01% | 3701 |
|
|
2019
Q2 | – | Sell |
-26,849
| Closed | -$186K | – | 4200 |
|
|
2019
Q1 | $186K | Buy |
26,849
+9,725
| +57% | +$67.4K | ﹤0.01% | 3893 |
|
|
2018
Q4 | $108K | Buy |
+17,124
| New | +$108K | ﹤0.01% | 3940 |
|